Cardinal Health, Inc. FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $222.6B |
| Gross margin | 3.7% |
| Operating income | $2.3B |
| Net income | $1.6B |
| Diluted EPS | $6.45 |
| Cash & equivalents | $3.9B |
| Total assets | $53.1B |
| Long-term debt | $8.0B |
Key takeaway
Cardinal Health generated $222.6 billion in revenue for fiscal 2025 with a thin 3.7% gross margin typical of pharmaceutical distribution.
🔒 4 more takeaways in the full analysis
Beneath the surface
Despite $3.874 billion in cash, total debt and lease obligations of $8.527 billion mean net debt is roughly $4.65 billion, a more meaningful leverage picture than the headline long-term debt figure alone suggests.
🔒 4 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 8 more findings — plus insider trades, activist stakes, and 8-K events for CAH.
Read the full analysis free Free account · 5 full analyses included · no card required